VY-3-135, CAS [[1824637-41-3]]

Produktübersicht

• Artikelname: VY-3-135, CAS [[1824637-41-3]]
• Artikelnummer: BYT-ORB1297911
• Hersteller Artikelnummer: orb1297911
• Alternativnummer: BYT-ORB1297911-1, BYT-ORB1297911-1, BYT-ORB1297911-10, BYT-ORB1297911-100, BYT-ORB1297911-25, BYT-ORB1297911-5, BYT-ORB1297911-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: breast cancer, ACSS2, Inhibitor, FattyAcidSynthase, Fatty Acid Synthase, inhibit, orally active, stable ACSS2 inhibitor, VY3135, VY-3-135, VY 3 135

Produktbeschreibung

VY-3-135 is a potent and selective oral ACSS2 inhibitor (IC50 = 44 nM) with no activity against ACSS1/ACSS3. It effectively blocks ACSS2-dependent fatty acid metabolism in vitro and in vivo, making it a valuable tool for researching cancer metabolism and metabolic disorders.

Produkteigenschaften

• Molekulargewicht: 429.51
• Reinheit: 99.79% (May vary between batches)
• CAS Nummer: [1824637-41-3]
• Formel: C26H27N3O3
• Target-Kategorie: Others,Acetyl-CoA Carboxylase,Fatty Acid Synthase

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: DMSO:46.67 mg/mL (108.66 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.66 mM)